Melatonin Fixes Jet Lag. For Ordinary Insomnia It Saves About 10 Minutes — and Most Products Have 10× Too Much

Educational journalism, not medical advice. Every claim here is checked against its cited sources by editor Tim Bunce — a health writer, not a physician. It isn’t specific to your situation: for health decisions, talk to your own clinician. How we work →

What melatonin actually does

Melatonin is a hormone produced by the pineal gland, secretion rising in the evening as ambient light drops and peaking in the middle of the night. Its primary role is signalling the timing of biological night to every cell in the body — not producing sleep directly. The sleepiness people associate with melatonin is downstream of this timing signal, not the primary effect.

This distinction explains the trial results. Melatonin produces:

• Modest reduction in sleep latency — 7-12 minutes faster onset in meta-analyses, similar to a placebo with a strong belief effect.
• Strong effects on circadian phase shifting — useful for jet lag and shift-work adjustment.
• Small effects on total sleep time — 8-15 additional minutes per night on average Ferracioli-Oda 2013.
• Strong effects on delayed sleep phase syndrome — people whose body clocks are shifted late.

Why 0.3-0.5mg outperforms 3-10mg

Endogenous melatonin peaks at blood concentrations corresponding to roughly 0.3mg oral intake. Higher doses produce supraphysiological levels — concentrations many times higher than the body ever produces naturally. Two problems follow:

• Receptor downregulation: chronically elevated melatonin causes the body to reduce receptor density. Effectiveness drops over 2-4 weeks of high-dose use.
• Persistent next-morning levels: high doses don’t clear by morning. The lingering signal produces grogginess, “hangover”, and disrupted next-night sleep onset.

Trials comparing 0.3mg to 5mg or 10mg consistently show 0.3mg produces equal or better sleep effects with no morning grogginess Zhdanova 2001. The 3-10mg products that dominate the retail shelf are 10-30x the optimal dose.

Timing matters

Two scenarios:

• For sleep-onset insomnia: take 0.3-0.5mg at 30-60 minutes before desired sleep. The phase-advancing effect helps initiate sleep faster.
• For circadian phase delay (you can’t get to sleep until 3am despite trying earlier): take 0.3-0.5mg 4-5 hours before your current sleep-onset time. Gradually advance the dose timing earlier across 2-3 weeks.
• For jet lag eastward: take 0.3-0.5mg at destination bedtime for 3-5 nights.
• For jet lag westward: usually doesn’t need melatonin — westward shifts align with the natural drift of human circadian rhythms.

“Doses in the 0.3-0.5mg range produce sleep effects equal or superior to the 3-10mg doses commonly marketed, with no next-day grogginess. Higher doses produce supraphysiological levels that persist into the next morning and downregulate receptors over time.”

— Zhdanova et al., Clin Pharmacol Ther, 2001 view source

What melatonin doesn’t do

• It’s not a sedative. If you’re anxious or your sleep environment is suboptimal, melatonin doesn’t make those issues go away.
• It doesn’t maintain sleep. Melatonin helps onset but doesn’t prevent middle-of-night awakening — that’s a different mechanism (cortisol regulation, autonomic balance, sleep environment).
• It doesn’t replace sleep hygiene. Heavy late-evening eating, alcohol, blue-light exposure, and irregular schedules disrupt sleep more than melatonin can fix.
• It’s not an antidote to caffeine. Caffeine and melatonin work through different receptors; the caffeine effect on sleep remains regardless of melatonin dose.

When CBT-I beats melatonin

For chronic insomnia (persistent sleep problems lasting weeks/months), cognitive-behavioural therapy for insomnia produces effects roughly 2-3 times larger than melatonin in head-to-head trials. CBT-I addresses the cognitive and behavioural patterns that maintain insomnia (clock-watching, in-bed wakefulness, anticipatory anxiety about sleep). It’s the first-line evidence-based intervention for chronic insomnia — melatonin is the supplement people reach for first but produces smaller and less durable effects.

Practical takeaways

• Melatonin is a circadian timing signal, not a sedative. Effective for circadian problems (jet lag, shift work, phase delay) but produces small effects on garden-variety insomnia.
• Use 0.3-0.5mg, not 3-10mg. Higher doses produce next-day grogginess and lose effectiveness over weeks.
• Timing matters. Take 30-60 min before sleep for onset; 4-5 hours earlier for phase shifts.
• Doesn’t maintain sleep, doesn’t replace sleep hygiene, doesn’t counter caffeine.
• For chronic insomnia: CBT-I produces larger and more durable effects than melatonin.

The label is often fiction

If you have decided melatonin is worth a try, the next problem is buying a product that contains what it claims. Dietary supplements in North America are not tested for accuracy before they reach the shelf, and melatonin is one of the worst offenders. When researchers bought 25 melatonin gummy products sold in the United States and measured the actual contents in a laboratory, 22 of the 25 (88 percent) were inaccurately labelled, and only 3 fell within 10 percent of the dose printed on the bottle Cohen 2023. The measured melatonin ranged from 74 percent to a startling 347 percent of the labelled amount — so a gummy sold as "10 mg" actually delivered as much as 13.1 mg, while another "melatonin" product contained no detectable melatonin at all, just 31.3 mg of CBD Cohen 2023.

This matters more than it might seem. The whole argument for the low 0.3–0.5 mg dose is that it mimics your body's own night-time melatonin levels; that precision is meaningless if the product silently contains four times what the label says. The practical defence is to ignore gummies — which are the hardest to dose accurately and the most variable in these tests — and to look for a product carrying an independent USP Verified mark, the seal of the United States Pharmacopeia's voluntary testing program, which confirms the supplement actually contains the labelled ingredients in the labelled amounts. Plain low-dose tablets from a USP-verified line are a far safer bet than a candy-shaped gummy of unknown strength.

Keep it locked away from children

The mislabelling problem becomes genuinely dangerous around small children, and the data here are not subtle. A report from the U.S. Centers for Disease Control and Prevention found that calls to poison-control centres for pediatric melatonin ingestion rose 530 percent over a decade — from 8,337 cases in 2012 to 52,563 in 2021 — totalling 260,435 reports, with children aged five and under making up 83.8 percent of them Lelak 2022. The overwhelming majority, 94.3 percent, were unintentional: a toddler finding a bottle of what looks and tastes like fruit candy. Most cases were mild, but the trend was not trivial — among children seen in a healthcare facility, 4,097 were hospitalised and 287 needed intensive care; five required mechanical ventilation and two children died Lelak 2022.

The gummy format is the heart of the problem: it is appealing, often sold in large jars, and — as the labelling study showed — frequently far stronger than advertised. If melatonin is in your house, treat it like any other medicine: store it high, out of sight, and in child-resistant packaging, not on a nightstand or kitchen counter. None of this means melatonin is uniquely toxic; it means an accessible, sweet, under-regulated product is a predictable hazard around young children.

Where the evidence is genuinely strong: kids and circadian disorders

The headline finding — that melatonin saves the average adult with ordinary insomnia only a handful of minutes — is true, but it would be unfair to leave the impression that melatonin is useless for everyone. There are two groups where the evidence is much more convincing, and in both the benefit comes from melatonin acting on the body clock rather than as a sedative.

The first is children with neurodevelopmental conditions such as autism, who frequently have disrupted melatonin signalling and severe difficulty falling asleep. A systematic review and meta-analysis of randomised, placebo-controlled trials in autistic children found that melatonin shortened the time to fall asleep by about 39 minutes and increased total sleep by about 44 minutes compared with placebo, with side effects described as minimal to none Rossignol 2011. That is a far larger effect than the 7–12 minutes seen in typical adult insomnia — but it is a specific clinical use, and because dosing and safety in children are not well established for the general population, the U.S. National Center for Complementary and Integrative Health advises parents to speak with a health-care provider before giving any child melatonin NCCIH 2022.

The second group is people whose body clock is shifted late — so-called delayed sleep-wake phase disorder, the "night owl" who genuinely cannot fall asleep until 3 a.m. no matter how tired they are. Here the American Academy of Sleep Medicine's clinical practice guideline gives a positive recommendation for strategically timed melatonin in adults with this condition, precisely because the goal is to nudge the circadian clock earlier rather than to force drowsiness Auger 2015. The crucial word is "timed": for a delayed clock the dose is taken in the early evening, hours before the desired bedtime, not at lights-out — which is exactly why a generic "take one at bedtime" instruction on the bottle misses the point for this condition.

Side effects and who should be cautious

For most healthy adults using it occasionally and at a low dose, melatonin's safety record is reassuring. NCCIH states that short-term use "appears to be safe for most people," while noting that good evidence on long-term, nightly use is simply lacking NCCIH 2022. The common side effects are mild and short-lived — headache, dizziness, nausea, and next-day drowsiness — the last of which is more likely with the oversized 3–10 mg doses discussed earlier NCCIH 2022.

Some people, however, should not start melatonin without a conversation with their clinician or pharmacist. NCCIH specifically flags that people with epilepsy and those taking blood-thinning (anticoagulant) medication should use melatonin only under medical supervision, because of potential interactions NCCIH 2022. Because melatonin is a hormone, its effects in pregnancy and breastfeeding are also unstudied, and NCCIH notes the safety research in those situations is missing NCCIH 2022 — a reasonable cue to default to non-drug approaches and ask a provider first. The broader lesson is consistency with the rest of this article: melatonin is a low-risk tool for the right person and the right purpose, but "natural" and "available without a prescription" are not the same as "harmless for everyone." If you take regular medication, have a chronic condition, are pregnant, or are considering it for a child, the few minutes it takes to check with a pharmacist are well spent.

Choosing between the two popular sleep supplements? See magnesium vs melatonin for sleep.

Melatonin is one piece of a bigger trend — see the viral sleep stack, by the evidence.

References